|
Q4 FY2026
As of Jun 27, 2026
|
Q3 FY2026
As of Mar 28, 2026
|
Q2 FY2026
As of Dec 27, 2025
|
Q1 FY2026
As of Sep 27, 2025
|
Q4 FY2025
As of Jun 28, 2025
|
Q3 FY2025
As of Mar 29, 2025
|
Q2 FY2025
As of Dec 28, 2024
|
Q1 FY2025
As of Sep 28, 2024
|
Q4 FY2024
As of Jun 29, 2024
|
Q3 FY2024
As of Mar 30, 2024
|
Q2 FY2024
As of Dec 30, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jul 1, 2023
|
Q3 FY2023
As of Apr 1, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Oct 1, 2022
|
Q4 FY2022
As of Jul 2, 2022
|
Q3 FY2022
As of Apr 2, 2022
|
Q2 FY2022
As of Jan 1, 2022
|
Q1 FY2022
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepayments and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Goodwill, net | ||||||||||||||||||||
| Intangibles, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll and related expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 1 million shares authorized, no shares issued or outstanding at June 27, 2026 and June 28, 2025 | ||||||||||||||||||||
| Common stock, $0.001 par value; 1 billion shares authorized; 247 million shares at June 27, 2026 and 223 million shares at June 28, 2025, issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Common Stock, issued (in shares) |
Loading...
